版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
NicetomeetyouNicetomeetyou1AcuteGlomerulonephritis
BeijingChildren’sHospitalaffiliatedtoCapitalUniversityofMedicalSciencesMengQunAcuteGlomerulonephritis
Beiji2AcuteGlomerulonephritisDefinitionEtiologyandPathogenesisPathologyClinicalfeaturesLaboratoryfindingsDiagnosisanddifferentialdiagnosisTreatmentAcuteGlomerulonephritisDefini3Definition
acuteonsetpostinfectiousglomerulonephritis:pharyngitisorpyodermaoftenbelongtoacutepoststreptococcalglomerulonephritis(APSGN)resultofinflammatoryglomerularinjuryDefinition
acuteonset4
Definitionhematuriaproteinuriaedemahypertensionrenalinsufficiency
Definitionhematuria5
commonage:5~14y<2y:raremale/female≈2/1self-limitedprognosis:finemorbidity:onthedecline
6
Etiologybacteria,viruses,mycoplasma…groupAβ-hemolyticstreptococcitype12:pharyngitistypes2,49,50,55,60:pyodermatype49:pharyngitisorpyoderma
Etiologybacteria,viruses,7Pathogenesis
secondarytoadirecttoxiceffectontheglomerulusofastreptococcalproteinthestreptococcalproductinduceanimmunecomplex-mediatedinjury
1)introducinganantigentotheglomrulus:plantedantigen2)depositionofcirculatingimmunecomplexes3)alteringanormalrenalantigentoaself-antigeninducinganautoimmuneresponsetotheself-antigen
Pathogenesissecondarytoadi8streptococcalantigenCICinsituICtriggerautoimmunitycomplementactivitedinflammatoryglomerularinjuryGBMdamagedhematuriaproteinuria
proliferativemesangialandendothelialcellsGFRoliguria,edema,hypertentionstreptococcalantigenCICinsit9Pathology
diffuseglobalhypercellularityproliferativemesangialandendothelialcellscrescentformationsubepithelialdepositioninterstitialedemainterstitialinfiltrationofleukocytePathology
diffuseglobalhyper10Clinicalfeatures
presentfromasymptomatictooliguricacuterenalfailurelatentperiod:afterpharyngitis:6~12daysafterskininfection:14~28daysClinicalfeatures
presentfrom11Nonspecificsymptomsandsigns
tirednessheadacheappetiteslightlyfevervomiting…
thesignofinfectionNonspecificsymptomsandsigns12Classicalmanifestation(1)
hematuria
grosshematuria:50~70%patientscoffee-coloredortea-coloredturntomicrohematuria:after1~2wClassicalmanifestation(1)
hem13Classicalmanifestation(2)edema:70%patientsreason:sodiumandfluidretentionpresents:faceperiorbitalupperextremitiesClassicalmanifestation(2)edem14腎炎腎病幻燈課件15Classicalmanifestation(3)hypertention:30~80%patientsmildtomoderate
schoolagepatients≥130/90mmHgpre-schoolagepatients≥120/80mmHgClassicalmanifestation(3)hype16Classicalmanifestation(4)proteinuria:theextentisvariousmost<3g/dnephrotic-rangeproteinuria:20%patientsurinevolume:Classicalmanifestation(4)prot17Severecase(1)
severehypervolemia:oftenoccurs<1weekoftheonsetofAGNcausedbysodiumandfluidretention
manifestations:dyspneacoughsevereedemaenlargedheartandliver…Severecase(1)
severehypervo18Severecase(2)hypertensiveencephalopathy:intheearlyonsetofAGNBP>150~160/100~110mmHgreason:CNSvasculitismanifestations:headachevomitingconfusionsomnolenceconvulsioncoma
Severecase(2)hypertensiveenc19Severecase(3)acuterenalfailure:last3~5d,<10dmesangialandendothelialcellsproliferationbloodvolumeofcapillaryglomerularfiltrationrate(GFR)Severecase(3)acuterenalfail20Non-Classicalmanifestation(1)
asymptomaticAGN:microhematuriawithoutotherclinicalmanifestation
contactingAGNpatientsorwhenstreptococciisepidemicNon-Classicalmanifestation(121Non-Classicalmanifestation(2)extrarenalAGN:edemahypertentionC3
ASOurinetest:nomalorslightlyabnomalNon-Classicalmanifestation(222Non-Classicalmanifestation(3)nephroticsyndromelikeAGN:severeedemahematuriaproteinuriahypoalbuminimiahypercolesteralimia
Non-Classicalmanifestation(323Laboratoryfindings(1)urine:dysmorphicredbloodcellredbloodcellcastscastsofleukocytesrenaltubuleepithelialcellshyalineandgranularcastsproteinuriaLaboratoryfindings(1)urine:24erythrocytesedimentationrate:antistreptolysinO(ASO):pharyngitis10~14daysofphasereachthehightesttiterin3~5weeks,returntonomalin3~6monthantideoxyribonucleaseB(+):pyodermaLaboratoryfindings(2)erythrocytesedimentationrate25complement:returntonormal<8weekscirculationgimmunecomplexes:(+)BUN,Cr:correlatewithdiseaseactivityLaboratoryfindings(3)complement:Laboratoryfindin26Diagnosisacuteonset+abnomalurinetestoredema,oliguria,hypertentionAPSGN:above+streptococcalinfectialdisease+increasedASO+decreasedC3Diagnosisacuteonset+abnomal27Differentialdiagnosis(1)
AGNcausedbyotheretiologiesandpathogenicmechanisms:suchasvirusesDifferentialdiagnosis(1)28Differentialdiagnosis(2)IgAnephropathy
latent:24-48hnoedema,hypertentionC3:normalDifferentialdiagnosis(2)IgAn29Differentialdiagnosis(3)ChronicGNwithacuteepisode:
latent:short(1~2days)patients:malnutritionanemiagrowthretardedrenalfunction:usuallyabnormalproteinuria:severegravityofurine:Differentialdiagnosis(3)Chron30Differentialdiagnosis(4)Idiopathicnephroticsyndrome:
ASO:normalPathology
Differentialdiagnosis(4)Idiop31Differentialdiagnosis(5)rapidlyprogressiveglomerulonephritis(crescenticglomerulonephritis)
oliguriaoranuriarapidlossofrenalfuntionsecondaryGN:LupusnephritisPurpuranephritisHBV-associatedglomerulonephritis
Differentialdiagnosis(5)rapid32Treatment
nospecifictreatmentsupportivecare
Treatmentnospecifictreatmen33Generaltreatment
stayinbed:2~3weekssaltintake:60mg/Kg.dlimitproteinintake:0.5g/Kg.d(azotemiaperiod)Generaltreatmentstayinbed34Appropriateantibiotictherapy
penicillinG:10~14days
otherantibiotics:
accordingtosensitivitytestAppropriateantibiotictherapy35
Othertreatment
Edema:controlliquidandsaltdiureticsHypertention:rest,controlliquidandsaltNifedipineCaptoprilOthertreatment
Edema:cont36Treatmentofseverecases(1)
Severehypervolemia:restricttheintakeofliquidandsaltloopdiuretics:furosemidesodiumnitroprussidedialyticsupportTreatmentofseverecases(1)S37Hypertensiveencephalopathy:
sodiumnitroprusside
controlconvulsionAcuterenalfailure:
comprehensivetherapyTreatmentofseverecases(2)
Hypertensiveencephalopathy:T38Prognosisandprevention
recovery:95%severecasesmayprogressedtochronicGNandCRFprevention:preventinfectionPrognosisandprevention
recov39NephroticSyndrome
NephroticSyndrome
40Definition(NS)
massiveproteinuriahypoproteinemiaedemahyperlipidemiaDefinition(NS)
massiveprot41mayoccurasaresultofanyformofglomerulardiseasemaybeassociatedwithavarietyofextrarenalconditionsaccordingtoetiology:primaryNS:simpleandnephritictypeNSsecondaryNScongenitalNSmayoccurasaresultofanyf42usuallyaffectspre-schoolchildrenthemostcommonage:3~5yearsmale/female≈3.7/1mostcommonformofnephropathyusuallyaffectspre-schoolchi43racialandgenomicandenviromentalbackground:nephrin--NPHS1,podocin…steroidresponsiveNS:
associatewithHLA-DR7frequentlyrelapse:
correlatewithHLA-DR9steroidresistantNS:NPHS2
racialandgenomicandenvirom44EtiologyandPathogenesis
unclear
thechangeofformationandelectronofcapillaryglomerularpermeabilitytoproteinEtiologyandPathogenesisuncl45minimalchangeNS:noimmunecomplexdepositionnegativechargeofbarrier:injury(cell-mediatedimmunity)non-minimalchangeNS:Igand/orCdepositatglomerrulidamagethefiltratedbarrierminimalchangeNS:46Physiopathology
Proteinuria:
themostbasicclinicalcharacterthefusionoffootprocessesofthevisceralepitheliumofGBMthenegativechargeglomrularpermeabilitytoproteinPhysiopathologyProteinuria:47Hypoproteinemiareason:thelossofalbumininurinesynthesisofalbuminnoproperintakingproteinserumalbuminisnegativelycorrelatedwiththeseverityofproteinuriaHypoproteinemiareason:48Edema
themostcommonsymptoms:1)hypoproteinemiaplasmaoncoticpressurehypovolemia2)serumalbumin<25g/Lfluidintotheinterstitialspace<15g/Lasites3)tubularsodiumreabsorption4)thedefectofNaarrangement5)serumADHEdemathemostcommonsympto49腎炎腎病幻燈課件50Hyperlipidemiahypercholesterolemiahypertriglyceridemiasynthesislow-densitylipoproteinscatabolismverylowdensitylipoproteinsdamagevasculatureinduceglomerulosclerosiscorrelatedwithhypoalbuminemiaproteinuriaHyperlipidemiahypercholeste51PathologyminimalchangeNS:76.4%membranoproliferativeGN:7.5%focalsegmentalglomerulosclerosis:6.9%mesangialproliferativeGN:2.3%focalglomerulosclerosis:1.7%membranousnephropathy:1.5%…………Pathology52MCNS:LightMicroscopynoglomerularlesionsminimalfocalsegmentalmesangialprominencethematrix:noexpandedtotheextentthatcapillarylumensarecompromisedcapillarywalls:thinandcapillarylumenspatentproteinandlipidresorptiondropletsintubularepithelialcellinterstitialedema:rareMCNS:LightMicroscopy53MCNS:
ElectronMicroscopytheeffacementofvisceralepithelialcellfootprocessesmicrovilloustransformationglomerularandproximaltubularepithelialcellshaveincreasedclearanddensecytoplasmicdropletsMCNS:ElectronMicroscopythee54MCNS:ImmunofluoresensesMicroscopynoremarkablefindingslow-levelmesangialstainingforIgMMCNS:ImmunofluoresensesMicro55membranoproliferativeGNmembranoproliferativeGN56mesangialproliferativeGNmesangialproliferativeGN57membranousnephropathymembranousnephropathy58ClinicalManifestation(1)
cardinalclinicalfeature:abruptonsetofedemaheavyproteinuriahypoalbuminemiahyperlipidemiaClinicalManifestation(1)card59ClinicalManifestation(2)hematuria:unusualhypertention:notcommontransientGFR:30%patientscausedbyhypovolemiathefunctionofrenal:nomalARF:rareClinicalManifestation(2)hemat60ComplicationsInfectionsElectrolitedisturbanceandhypovolemiaHypercoagulabilityandthrombosisAcuterenalfailureTubularfunctionlesionGrowthretardedComplications61Laboratoryfindingsurineanalysis:
proteinuria:≥40mg/h.m2
or≥50mg/kg.dUpro/Ucr≥3.5microscopichematuria:<15%patientshyalineandgranularcastsLaboratoryfindingsurineanal62erythrocytesedimentationrate:serumalbuminconcentration:totalcholesteral,LDL,triglyceride:serumcomplement:usuallynormalothers:plasmaviscosityRBCaggregation,PLT,fibrinogenplasminogenandantithrombinIIIrenalfunction:usuallynormalLaboratoryfindingserythrocytesedimentationrate63Diagnosis(simpletypeNS)
proteinuria:+++~++++≥40mg/h.m2or≥50mg/kg.d
hypoproteinemia
ALB<30/L
hyperlipidemia:
TC>5.72mmol/Lor220mg/dl
edemaDiagnosis(simpletypeNS)pr64Differentialdiagnosis(1)
NephritictypeNS
abovepoints+atleast?asfollowsurinetest:dysmorphicredbloodcellRBC>10/HP>3times2weekshypertention:schoolagechildren≥130/90mmHgpre-schoolagechildren≥120/80mmHgrenalfunctioninsufficiencypersistentcomplementDifferentialdiagnosis(1)65SecondaryNS:
APSGNLupusnephritisPurpuranephritisHBV-associatedglomerulonephritis…Differentialdiagnosis(2)
SecondaryNS:Differentialdia66Treatment:Generaltreatment
restinbeddietary:salt1~2g/dhighqualityprotein1.5~2g/kg.dVitD400u/d,Casevereedemaandhypertension:
limitliquidandsaltantihypertensiondiureticscontrolandpreventinfectionknowledgeeducation
Treatment:Generaltreatment67CorticosteroidtherapyPrednisone:2mg/kg.dmaximum60mg/dprinciple:
enoughdosageslowlytaperlongremainVitD,CalciumCorticosteroidtherapyPredniso68Newpatients:
shorttermtherapy:8weeksprednisone2mg/kg.d×4w1.5mg/kg.qod×4wmiddle~longtermtherapy:6~9monthsprednisone1.5~2mg/kg.d×4~8wQOD×4wslowlytaper
Newpatients:
shorttermthera69SideeffectsofsteroidAlteredglucosemetabolism:hyperglycemiaandglycosuriaCessationofgrowthCushingoidhabitusElevatedbloodpressureBehaviorandpersonalitychangesHypercoagulatorystate,thrombosisAdrenalinsufficiencyInfectionOsteoporosis…………SideeffectsofsteroidAltered70SomeconceptsSteroid-responsiveNS:pred≤8w,Upro(-)Steroid-resistantNS:pred≥8w,Upro(+)Steroid-dependentNS:responsetosteroidtaperordiscontinued<1month,relapse≥2timesRelapse:Upro(-)Upro(+)>2wFrequentlyrelapse:<6monrelapse≥2times<1yearrelapse≥3timesSomeconceptsSteroid-responsiv71Frequentlyrelapseor
steroiddependentpatients:
adjustthesteroiddosageadjustperiodofsteroidchangetoothersteroid:dexamethasonemethylprednisoloneFrequentlyrelapseor
steroid72Immunosuppressivetherapy
frequentlyrelapsesteroiddependentsteroidresistantserioussideeffectswithsteroidtherapyCyclophosphamide,cyclosporinA,…Immunosuppressivetherapyfreq73Cyclophosphamide2~2.5mg/kg.dTidpo×8~12w<200mg/kg10~12mg/kg.div×2d/2w<150mg/kg500mg/m2iv/mon×6~8m<200mg/kgSideeffects:bonemarrowsuppression(WBCPLT)liverfunctionhemorrhagiccystitisgonadaldysfunctionCyclophosphamide2~2.5mg/kg.d74Anticoagulant
SodiumHeparin:1mg/kg.d2~4weeksivUrikinase:3~60000u/d1~2weeksivDipyridamole:5~10mg/kg.dpoTid×6mAnticoagulant
SodiumHeparin75Enhanceimmunefunction
Levamisole:2.5mg/kg,dQod×6mImmunogloblin:400mg/kg.d×5daysEnhanceimmunefunction
Levami76Angiotensinconvertingenzymeinhibitor
(ACEI)CaptoprilEnalaprilFosinoprilTraditionalherbs
OthersAngiotensinconvertingenzyme77Criteriaofrecoveryclinicalcured:
stoptreatmentfor3yearstotalremissionnorelapsetotalremission:laboratorytestisnomal.partremission:proteinuria<+++noremission:proteinuria>+++Criteriaofrecoveryclinicalc78PrognosiscloselycorrelatedwithpathologyminimalchangeNS:finePrognosis79ClinicalfeaturesofthevarioustypesofpathologyofNSMCNSFSGSMPGNMNAgeMale/femaleHematuriaBPSCrC3SensitivetosteriodPrognosisRecurrenceaftertransplantation1~6everyage6~161~142/13/21/13/1AfewmanymanymanyAfewsomemanysomeAfewsomemanysome--68%+-93%25%--Goodbadbadnotsobad-++someClinicalfeaturesofthevario80DifferencesbetweenchildrenandadultswithNS
childrenadults24hUpro>50mg/kg>3.5gpathologyMCNSMNetiolgyprimaryNSsecondaryNSresponsetosteroidmostwellsomewellDifferencesbetweenchildrena81case12yearsmaleEarlymorningfacialedema×5daysgeneralizededemawithascites×3daysurineoutputdiminishedCurrentimmunizationPhysicalexaminationuncomfortable-appearingobviousanasarcaBP95/58mmHgperiorbitaledema++breathsoundsdiminishedhearttonesnormalabdomendistendedfluidwave+pittingedemaofthelowerextremities+++norashjointsnormalcase12yearsmale82Nofamilyhistoryofrenaldiseasew15kgUrinalysis:pro+++γ1.030PH5.5RBC-cast–Urineculture:-Hemogram:normalComplement:normalANA:-HepatitisBsurfaceantigen:-Albumin:25g/LBUN:normalCholesterol:8.9mmol/L24-hrurinetotalprotein:1.8gTuberculintest:-Nofamilyhistoryofrenaldis83questionsWhatisthediagnosis?MakedifferentialdiagnosisHowtotreatthepatient?questionsWhatisthediagnosis84case28yearsmaleEarlymorningfacialedema×5daysgeneralizededemawithascites×3dayscoffee-coloredurineoliguriaHadupperrespiratoryinfection2weeksagoCurrentimmunizationPhysicalexaminationuncomfortable-appearingBP105/70mmHgperiorbitaledema++breathsoundsdiminishedhearttonesnormalabdomendistendedfluidwave+pittingedemaofthelowerextremities+++norashjointsnormalcase28yearsmale85Nofamilyhistoryofrenaldiseasew30kgUrinalysis:pro+++γ1.030PH5.5RBC+++Urineculture:-Hemogram:Hb10g/LANA:-HepatitisBsurfaceantigen:-Albumin:20g/LBUN:normalCholesterol:8.5mmol/L24-hrurinetotalprotein:3.0gTuberculintest:-ASOCNofamilyhistoryofrenaldis86Thankyou!Thankyou!87NicetomeetyouNicetomeetyou88AcuteGlomerulonephritis
BeijingChildren’sHospitalaffiliatedtoCapitalUniversityofMedicalSciencesMengQunAcuteGlomerulonephritis
Beiji89AcuteGlomerulonephritisDefinitionEtiologyandPathogenesisPathologyClinicalfeaturesLaboratoryfindingsDiagnosisanddifferentialdiagnosisTreatmentAcuteGlomerulonephritisDefini90Definition
acuteonsetpostinfectiousglomerulonephritis:pharyngitisorpyodermaoftenbelongtoacutepoststreptococcalglomerulonephritis(APSGN)resultofinflammatoryglomerularinjuryDefinition
acuteonset91
Definitionhematuriaproteinuriaedemahypertensionrenalinsufficiency
Definitionhematuria92
commonage:5~14y<2y:raremale/female≈2/1self-limitedprognosis:finemorbidity:onthedecline
93
Etiologybacteria,viruses,mycoplasma…groupAβ-hemolyticstreptococcitype12:pharyngitistypes2,49,50,55,60:pyodermatype49:pharyngitisorpyoderma
Etiologybacteria,viruses,94Pathogenesis
secondarytoadirecttoxiceffectontheglomerulusofastreptococcalproteinthestreptococcalproductinduceanimmunecomplex-mediatedinjury
1)introducinganantigentotheglomrulus:plantedantigen2)depositionofcirculatingimmunecomplexes3)alteringanormalrenalantigentoaself-antigeninducinganautoimmuneresponsetotheself-antigen
Pathogenesissecondarytoadi95streptococcalantigenCICinsituICtriggerautoimmunitycomplementactivitedinflammatoryglomerularinjuryGBMdamagedhematuriaproteinuria
proliferativemesangialandendothelialcellsGFRoliguria,edema,hypertentionstreptococcalantigenCICinsit96Pathology
diffuseglobalhypercellularityproliferativemesangialandendothelialcellscrescentformationsubepithelialdepositioninterstitialedemainterstitialinfiltrationofleukocytePathology
diffuseglobalhyper97Clinicalfeatures
presentfromasymptomatictooliguricacuterenalfailurelatentperiod:afterpharyngitis:6~12daysafterskininfection:14~28daysClinicalfeatures
presentfrom98Nonspecificsymptomsandsigns
tirednessheadacheappetiteslightlyfevervomiting…
thesignofinfectionNonspecificsymptomsandsigns99Classicalmanifestation(1)
hematuria
grosshematuria:50~70%patientscoffee-coloredortea-coloredturntomicrohematuria:after1~2wClassicalmanifestation(1)
hem100Classicalmanifestation(2)edema:70%patientsreason:sodiumandfluidretentionpresents:faceperiorbitalupperextremitiesClassicalmanifestation(2)edem101腎炎腎病幻燈課件102Classicalmanifestation(3)hypertention:30~80%patientsmildtomoderate
schoolagepatients≥130/90mmHgpre-schoolagepatients≥120/80mmHgClassicalmanifestation(3)hype103Classicalmanifestation(4)proteinuria:theextentisvariousmost<3g/dnephrotic-rangeproteinuria:20%patientsurinevolume:Classicalmanifestation(4)prot104Severecase(1)
severehypervolemia:oftenoccurs<1weekoftheonsetofAGNcausedbysodiumandfluidretention
manifestations:dyspneacoughsevereedemaenlargedheartandliver…Severecase(1)
severehypervo105Severecase(2)hypertensiveencephalopathy:intheearlyonsetofAGNBP>150~160/100~110mmHgreason:CNSvasculitismanifestations:headachevomitingconfusionsomnolenceconvulsioncoma
Severecase(2)hypertensiveenc106Severecase(3)acuterenalfailure:last3~5d,<10dmesangialandendothelialcellsproliferationbloodvolumeofcapillaryglomerularfiltrationrate(GFR)Severecase(3)acuterenalfail107Non-Classicalmanifestation(1)
asymptomaticAGN:microhematuriawithoutotherclinicalmanifestation
contactingAGNpatientsorwhenstreptococciisepidemicNon-Classicalmanifestation(1108Non-Classicalmanifestation(2)extrarenalAGN:edemahypertentionC3
ASOurinetest:nomalorslightlyabnomalNon-Classicalmanifestation(2109Non-Classicalmanifestation(3)nephroticsyndromelikeAGN:severeedemahematuriaproteinuriahypoalbuminimiahypercolesteralimia
Non-Classicalmanifestation(3110Laboratoryfindings(1)urine:dysmorphicredbloodcellredbloodcellcastscastsofleukocytesrenaltubuleepithelialcellshyalineandgranularcastsproteinuriaLaboratoryfindings(1)urine:111erythrocytesedimentationrate:antistreptolysinO(ASO):pharyngitis10~14daysofphasereachthehightesttiterin3~5weeks,returntonomalin3~6monthantideoxyribonucleaseB(+):pyodermaLaboratoryfindings(2)erythrocytesedimentationrate112complement:returntonormal<8weekscirculationgimmunecomplexes:(+)BUN,Cr:correlatewithdiseaseactivityLaboratoryfindings(3)complement:Laboratoryfindin113Diagnosisacuteonset+abnomalurinetestoredema,oliguria,hypertentionAPSGN:above+streptococcalinfectialdisease+increasedASO+decreasedC3Diagnosisacuteonset+abnomal114Differentialdiagnosis(1)
AGNcausedbyotheretiologiesandpathogenicmechanisms:suchasvirusesDifferentialdiagnosis(1)115Differentialdiagnosis(2)IgAnephropathy
latent:24-48hnoedema,hypertentionC3:normalDifferentialdiagnosis(2)IgAn116Differentialdiagnosis(3)ChronicGNwithacuteepisode:
latent:short(1~2days)patients:malnutritionanemiagrowthretardedrenalfunction:usuallyabnormalproteinuria:severegravityofurine:Differentialdiagnosis(3)Chron117Differentialdiagnosis(4)Idiopathicnephroticsyndrome:
ASO:normalPathology
Differentialdiagnosis(4)Idiop118Differentialdiagnosis(5)rapidlyprogressiveglomerulonephritis(crescenticglomerulonephritis)
oliguriaoranuriarapidlossofrenalfuntionsecondaryGN:LupusnephritisPurpuranephritisHBV-associatedglomerulonephritis
Differentialdiagnosis(5)rapid119Treatment
nospecifictreatmentsupportivecare
Treatmentnospecifictreatmen120Generaltreatment
stayinbed:2~3weekssaltintake:60mg/Kg.dlimitproteinintake:0.5g/Kg.d(azotemiaperiod)Generaltreatmentstayinbed121Appropriateantibiotictherapy
penicillinG:10~14days
otherantibiotics:
accordingtosensitivitytestAppropriateantibiotictherapy122
Othertreatment
Edema:controlliquidandsaltdiureticsHypertention:rest,controlliquidandsaltNifedipineCaptoprilOthertreatment
Edema:cont123Treatmentofseverecases(1)
Severehypervolemia:restricttheintakeofliquidandsaltloopdiuretics:furosemidesodiumnitroprussidedialyticsupportTreatmentofseverecases(1)S124Hypertensiveencephalopathy:
sodiumnitroprusside
controlconvulsionAcuterenalfailure:
comprehensivetherapyTreatmentofseverecases(2)
Hypertensiveencephalopathy:T125Prognosisandprevention
recovery:95%severecasesmayprogressedtochronicGNandCRFprevention:preventinfectionPrognosisandprevention
recov126NephroticSyndrome
NephroticSyndrome
127Definition(NS)
massiveproteinuriahypoproteinemiaedemahyperlipidemiaDefinition(NS)
massiveprot128mayoccurasaresultofanyformofglomerulardiseasemaybeassociatedwithavarietyofextrarenalconditionsaccordingtoetiology:primaryNS:simpleandnephritictypeNSsecondaryNScongenitalNSmayoccurasaresultofanyf129usuallyaffectspre-schoolchildrenthemostcommonage:3~5yearsmale/female≈3.7/1mostcommonformofnephropathyusuallyaffectspre-schoolchi130racialandgenomicandenviromentalbackground:nephrin--NPHS1,podocin…steroidresponsiveNS:
associatewithHLA-DR7
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 生理學(xué)核心概念:系統(tǒng)功能與潛水醫(yī)學(xué)課件
- 藥理學(xué)入門(mén):右美沙芬鎮(zhèn)咳藥課件
- 腮腺混合瘤患者的隨訪管理
- 災(zāi)難事件后常見(jiàn)的心理問(wèn)題專(zhuān)家講座
- 湖南省衡陽(yáng)市部分學(xué)校聯(lián)考2025-2026學(xué)年八年級(jí)上學(xué)期期中語(yǔ)文試題(含答案)(含解析)
- 二次供水衛(wèi)生安全制度
- 2025-2030細(xì)胞治療產(chǎn)品商業(yè)化生產(chǎn)瓶頸與CDMO平臺(tái)建設(shè)需求分析
- 2025-2030細(xì)胞培養(yǎng)配套試劑市場(chǎng)集中度與渠道變革研究
- 2025-2030細(xì)胞培養(yǎng)肉技術(shù)突破與規(guī)?;a(chǎn)成本分析
- 2025-2030紐埃制藥行業(yè)市場(chǎng)規(guī)模深度調(diào)研與發(fā)展趨勢(shì)預(yù)測(cè)報(bào)告
- 2024-2025學(xué)年四川省綿陽(yáng)市七年級(jí)(上)期末數(shù)學(xué)試卷
- SF-36評(píng)估量表簡(jiǎn)介
- 道路清掃保潔、垃圾收運(yùn)及綠化服務(wù)方案投標(biāo)文件(技術(shù)標(biāo))
- 合成藥物催化技術(shù)
- 河南省三門(mén)峽市2024-2025學(xué)年高二上學(xué)期期末調(diào)研考試英語(yǔ)試卷(含答案無(wú)聽(tīng)力音頻及聽(tīng)力原文)
- 【語(yǔ)文】福建省福州市烏山小學(xué)小學(xué)三年級(jí)上冊(cè)期末試題(含答案)
- 建立鄉(xiāng)鎮(zhèn)衛(wèi)生院孕情第一時(shí)間發(fā)現(xiàn)制度或流程
- 睡眠科普課課件
- 2025年中級(jí)衛(wèi)生職稱(chēng)-主治醫(yī)師-放射醫(yī)學(xué)(中級(jí))代碼:344歷年參考題庫(kù)含答案解析(5卷)
- 2025年中國(guó)民航科學(xué)技術(shù)研究院招聘考試筆試試題(含答案)
- eol物料管理辦法
評(píng)論
0/150
提交評(píng)論